R&D Systems™ Recombinant Human ErbB2/Her2 Fc Chimera Protein

Catalog No.	Quantity
11-29E-R01M	1 mg

Catalog No. 11-29E-R01M Supplier R&D Systems™ Supplier No. 1129ER01M

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human ErbB2/Her2 Fc Chimera Protein is derived from NS0. The Recombinant Human ErbB2/Her2 Fc Chimera Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: NP_004439
• Characterization: Bioactivity
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 2064
• Molecular Weight (g/mol): 96.8kDa (monomer)
• Quantity: 1 mg
• Source: Mouse myeloma cell line,NS0-derived human ErbB2/Her2 protein, (N-terminus) Human Erb B2 (Thr23-Thr652) Accession &Num; NP_004439 IEGRMD Human IgG1 (Pro100-Lys330) 6 His-tag (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10EU per 1μg of the protein by the LAL method.
• Gene Symbol: ERBB2
• Product Type: Recombinant Protein
• Conjugate: Unconjugated
• Species: Human
• Reconstitution: Reconstitute at 100μg/mL in sterile PBS.
• Purity or Quality Grade: >90%, by SDS-PAGE with silver staining